Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways
Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways is a paper indexed in PICO Portal from OpenAlex.
How many citations does Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways have?
Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways has 126 citations in the OpenAlex counts PICO Portal stores.
When was Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways published?
Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways has 2014 year in the PICO Portal index.
What is the open-access status of Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways?
Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways has closed oa status in the PICO Portal index.
What is the DOI of Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways?
The DOI for Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways is on the source record.
What is the PMID of Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways?
The PMID for Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways is on the source record.
What is the OpenAlex record for Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways?
The OpenAlex for Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways is on the source record.